Jeff Evanson
2023
In 2023, Jeff Evanson earned a total compensation of $718.2K as Chief Commercial Officer at Outlook Therapeutics, a 49% decrease compared to previous year.
Compensation breakdown
| Option Awards | $267,025 |
|---|---|
| Salary | $450,000 |
| Other | $1,170 |
| Total | $718,195 |
Evanson received $450K in salary, accounting for 63% of the total pay in 2023.
Evanson also received $267K in option awards and $1.2K in other compensation.
Rankings
In 2023, Jeff Evanson's compensation ranked 1,568th out of 2,918 executives tracked by ExecPay. In other words, Evanson earned more than 46.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,568 out of 2,918 | 46th |
Division Manufacturing | 920 out of 1,608 | 43rd |
Major group Chemicals And Allied Products | 592 out of 901 | 34th |
Industry group Drugs | 576 out of 864 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 157 out of 211 | 26th |
Source: SEC filing on February 8, 2024.
Evanson's colleagues
We found two more compensation records of executives who worked with Jeff Evanson at Outlook Therapeutics in 2023.
News
Outlook Therapeutics CEO C Trenary's 2023 pay jumps 32% to $1.8M
February 8, 2024
Outlook Therapeutics Chief Operations Officer Terry Dagnon's 2022 pay jumps 378% to $1.4M
February 15, 2023
Outlook Therapeutics CEO C Trenary receives $7.5M in 2021
January 27, 2022
Outlook Therapeutics CEO Lawrence Kenyon's 2020 pay falls 36% to $1.2M
February 22, 2021